Max Taubert
Impact in
-
- Antibiotic Use and Resistance
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacogenetics and Drug Metabolism
Papers in
- Pharmacology 14
- Antibiotics Pharmacokinetics and Efficacy 12
- Pharmacogenetics and Drug Metabolism 4
-
- Antimicrobial Resistance in Staphylococcus 3
- Co-authors
- Uwe Fuhr (32 shared papers)Michael Zöller (7 shared papers)Michael Vogeser (4 shared papers)Sebastian Frechen (5 shared papers)Christina Scharf (4 shared papers)Johannes Zander (5 shared papers)Xia Li (5 shared papers)Lorenz Frey (2 shared papers)
- Journals
- European Journal of Clinical Pharmacology (5 papers)Antimicrobial Agents and Chemotherapy (5 papers)Clinical Pharmacology & Therapeutics (3 papers)Scientific Reports (3 papers)The Journal of Clinical Pharmacology (3 papers)
- Partner nations
- GermanyChinaSaudi Arabia
In The Last Decade
Max Taubert
40 papers receiving 503 citations
Peers
Comparison fields: 5 of 82
- Applied Microbiology and Biotechnology 28
- Pharmacology 161
- Molecular Medicine 47
- Pharmacology 65
- Internal Medicine 16
Countries citing papers authored by Max Taubert
This map shows the geographic impact of Max Taubert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Taubert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Taubert more than expected).
Fields of papers citing papers by Max Taubert
This network shows the impact of papers produced by Max Taubert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Taubert. The network helps show where Max Taubert may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Taubert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 64 | |
| 2 | 2019 | 50 | |
| 3 | 2020 | 49 | |
| 4 | 2016 | 47 | |
| 5 | 2019 | 29 | |
| 6 | 2017 | 26 | |
| 7 | 2021 | 24 | |
| 8 | 2021 | 20 | |
| 9 | 2018 | 19 | |
| 10 | 2018 | 17 | |
| 11 | 2020 | 16 | |
| 12 | 2020 | 15 | |
| 13 | 2018 | 13 | |
| 14 | 2020 | 12 | |
| 15 | 2019 | 10 | |
| 16 | 2023 | 9 | |
| 17 | 2020 | 9 | |
| 18 | 2018 | 9 | |
| 19 | 2020 | 8 | |
| 20 | 2023 | 8 |
About Max Taubert
Max Taubert is a scholar working on Pharmacology, Infectious Diseases, Oncology, Pediatrics, Perinatology and Child Health and Pharmacology, having authored 43 papers that have together received 508 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (12 papers), Drug Transport and Resistance Mechanisms (5 papers), Pharmacogenetics and Drug Metabolism (4 papers), Chronic Kidney Disease and Diabetes (3 papers), Antibiotic Resistance in Bacteria (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Atrial Fibrillation Management and Outcomes (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (28 citations), Pharmacology (161 citations), Molecular Medicine (47 citations), Pharmacology (65 citations) and Internal Medicine (16 citations). Max Taubert has collaborated with scholars based in Germany, China and Saudi Arabia. Frequent co-authors include Uwe Fuhr, Michael Zöller, Michael Vogeser, Sebastian Frechen, Christina Scharf, Johannes Zander, Xia Li, Lorenz Frey, Martin H. J. Wiesen and Uwe Liebchen. Their work appears in journals such as European Journal of Clinical Pharmacology, Antimicrobial Agents and Chemotherapy, Clinical Pharmacology & Therapeutics, Scientific Reports and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.